1. One-Prime Multi-Boost Strategy Immunization with Recombinant DNA, Adenovirus, and MVA Vector Vaccines Expressing HPV16 L1 Induces Potent, Sustained, and Specific Immune Response in Mice.
http://www.ncbi.nlm.nih.gov/pubmed/26821205
2. A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5.
http://www.ncbi.nlm.nih.gov/pubmed/26750243
3. HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions.
http://www.ncbi.nlm.nih.gov/pubmed/26727228
4. Human papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C.
http://www.ncbi.nlm.nih.gov/pubmed/26665182
5. Study of intact virus-like particles of human papillomavirus by capillary electrophoresis.
http://www.ncbi.nlm.nih.gov/pubmed/26634429
6. High-level production of Human Papillomavirus (HPV) type 16 L1 in Escherichia coli.
http://www.ncbi.nlm.nih.gov/pubmed/26608168
7. Human Papillomavirus Vaccine: State of the Art and Future Perspectives.
http://www.ncbi.nlm.nih.gov/pubmed/26572981
8. A Cell-Free Assembly System for Generating Infectious Human Papillomavirus 16 Capsids Implicates a Size Discrimination Mechanism for Preferential Viral Genome Packaging.
http://www.ncbi.nlm.nih.gov/pubmed/26559838
9. Herpes Simplex Virus downregulation of secretory leukocyte protease inhibitor enhances Human Papillomavirus type 16 infection.
http://www.ncbi.nlm.nih.gov/pubmed/26555393
10. [Immune response in cervical cancer. Strategies for the development of therapeutic vaccines].
http://www.ncbi.nlm.nih.gov/pubmed/26462518
ids:
26821205 26750243 26727228 26665182 26634429 26608168 26572981 26559838 26555393 26462518
Cristela Moreno Posted from WordPress for Android
Leave a comment